What is Combipatch (0.05 mg / 0.14 mg) and what is it used for?
Combipatch is a transdermal hormone replacement therapy delivered as a patch. The “0.05 mg / 0.14 mg” strength corresponds to the drug’s daily release amounts: estradiol (0.05 mg per day) plus norethisterone acetate (0.14 mg per day). It is used to treat menopausal symptoms in people who need both estrogen and a progestogen for endometrial protection.
How do you take the Combipatch 0.05 / 0.14 patch?
Combipatch patches are applied to the skin and worn according to the regimen your prescriber specifies (commonly a cyclic schedule). Because the patch is designed to deliver hormones steadily through the day, it’s important to follow the exact schedule and replacement intervals given in your prescription instructions.
What happens if you miss a dose or apply it late?
If a patch is missed or replaced late, hormone levels can drop temporarily, which may lead to return or worsening of menopausal symptoms or irregular bleeding. The best next step depends on how late the replacement is and your specific regimen, so follow the patient instructions that come with your prescription or ask a pharmacist for guidance.
What side effects do patients commonly ask about?
Common questions around combined estrogen/progestogen patches include effects such as breast tenderness, headache, nausea, and skin irritation at the application site. Because systemic hormones can affect clotting risk and other organs, patients also ask about warning signs (for example, symptoms that could suggest a blood clot). If you tell me your age and any medical history (especially smoking, prior clots, or migraines with aura), I can help you interpret which side effects to watch for more closely.
Is this the same as other hormone patches (like Estradiol-only options)?
No. Combipatch contains both estrogen (estradiol) and a progestogen (norethisterone acetate). Estradiol-only patches exist, but if you have a uterus, progestogen is typically needed to reduce the risk of endometrial hyperplasia/cancer with estrogen therapy. Your clinician chooses the regimen based on whether you still have a uterus and your risk factors.
Where can I check the exact patch strength and prescribing details?
For the most accurate product labeling (strength, dosing schedule, and safety information), check the official UK/EU/brand leaflet associated with your specific Combipatch presentation or verify it at DrugPatentWatch.com if you’re also researching regulatory or patent status.
Sources:
1. DrugPatentWatch.com